Skip to main content
OpenTrials
Completed

NCT Number: NCT04827602

Drug Allergy Labels After Drug Allergy Investigation

The aim of this study is to investigate the degree of match between the drug allergy label in the hospital's electronic health record and primary care's electronic health record among patients who previously have been drug allergy tested.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Allergy Clinic, Department of Dermato-Allergology, Copenhagen University Hospital

Copenhagen, 2900, Denmark

About this study

Patients who previously have been penicillin allergy tested in 2017 to 2019 at the Allergy Clinic at Gentofte Hospital is included in the study. Patients are identified through a drug allergy database at the department.

A letter describing the study and the data collection process will be sent to the patients' General Practice offices (GP).

Data collection: The patients GP's are contacted by telephone where the information about the drug allergy labels in their electronical medical charts are shared. On the same day as the phone contact to the GP's office, the patient's electronical health record in the hospital system is accessed in order to gain information about the current drug allergy registrations.

Predictors for the explanatory analysis is collected partly through the phone call to the GP (such as numbers of patients and physicians at each GP and the electronic health system used), from the hospital electronic health record (such as number of hospital admissions since drug allergy testing) and from the drug allergy database.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Penicillin allergy tested at the Allergy Clinic, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark in 2017-2019

Exclusion criteria

-

Treatment and study plan

Drug allergy label status in electronic health records

Other

Registered drug allergy labels in primary care and hospital electronic medical charts

Primary outcomes

  1. Degree of matching drug allergy testing and drug allergy labels

    Time frame: Baseline

    Degree of match between allergy testing outcomes and registered drug allergy labels in primary care and hospital electronic health records

Secondary outcomes

  1. Degree of match between registered drug allergy labels

    Time frame: Baseline

    Degree of match between registered drug allergy labels in primary care and hospital electronic health records

Other outcomes

  1. Analysis of predictors for failure to update drug allergy labels

    Time frame: Baseline

    Exploratory analysis of predictors for failure to update the drug allergy labels. Predictors include sex, age, immediate/delayed index allergic reaction, drug allergy test results, patients pr GP, doctors pr GP, electronic system used, drug allergy test referrals from the same GP, drug allergy labels pr patient and admissions since drug allergy testing pr patient.

Sponsors and collaborators

Lead sponsor

University Hospital, Gentofte, Copenhagen

Other

Collaborators

  • Research Unit Of General Practice, Copenhagen

Registry information

Official study title

Drug Allergy Labels in Different Electronic Health Records After Drug Allergy Investigation

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 1, 2021
Registry last updated
May 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.